400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Neuronal Signaling / CGRP Receptor / Ubrogepant
CAS No.: 1374248-77-7
Synonyms: MK-1602;Ubrelvy
Ubrogepant is an oral calcitonin gene-related peptide receptor (CGRP) antagonist in development for acute treatment of migraine.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT01613248 | Migraine | Phase 2 | Completed | - | - |
NCT01657370 | Migraine | Phase 2 | Completed | - | - |
NCT01657370 | - | - | Completed | - | - |
实验方案
技术信息
CAS号 | 1374248-77-7 | 储存条件 |
|
|
分子式 | C29H26F3N5O3 | 运输 | 蓝冰 | |
分子量 | 549.54 | 别名 | MK-1602;Ubrelvy |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT01613248 | Migraine | Phase 2 | Completed | - | - |
NCT01657370 | Migraine | Phase 2 | Completed | - | - |
NCT01657370 | - | - | Completed | - | - |
NCT02867709 | Migraine, With or Without Aura | Phase 3 | Completed | - | - |
NCT01613248 | - | - | Completed | - | - |
NCT02873221 | Migraine, With or Without Aura | Phase 3 | Completed | - | - |
NCT02828020 | Migraine, With or Without Aura | Phase 3 | Completed | - | - |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网